IL10 and Cognitive impairment: These results suggest that NK210 and NK219 can alleviate colitis and cognitive impairment by regulating the expression of inflammatory and anti-inflammatory cytokines (IFN-γ to IL-10 and/or TNF-α to IL-10 expression ratios).